Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March.
The item "Working-Capital-Turnover" stands at 3.20 as of 06/30/2025, the highest value at least since 03/31/2022, the period currently displayed.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Working Capital Turnover" stands at 3.20. This represents an increase of 2.04 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 87.30 percent compared to the value the year prior.
The 1 year change in percent is 87.30.
The 3 year change in percent is 186.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Working Capital Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Working Capital Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Working Capital Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Working Capital Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Working Capital Turnover | 280,205,508,085.11 |